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Abstract Connexins are four-transmembrane-domain
proteins expressed in all vertebrates which form permeable
gap junction channels that connect cells. Here, we analysed
Connexin-43 (Cx43) transport to the plasma membrane and
studied the effects of small GTPases acting along the
secretory pathway. We show that both GTP- and GDP-
restricted Sar1 prevents exit of Cx43 from the endoplasmic
reticulum (ER), but only GTP-restricted Sar1 arrests Cx43
in COP II-coated ER exit sites and accumulates 14-3-3
proteins in the ER fraction. FRET-FLIM data conﬁrm that
already in ER exit sites Cx43 exists in oligomeric form,
suggesting an in vivo role for 14-3-3 in Cx43 oligomeri-
zation. Exit of Cx43 from the ER can be blocked by other
factors—such as expression of the b subunit of the COP I
coat or p50/dynamitin that acts on the microtubule-based
dynein motor complex. GTP-restricted Arf1 blocks Cx43
in the Golgi. Lastly, we show that GTP-restricted Arf6
removes Cx43 gap junction plaques from the cell–cell
interface and targets them to degradation. These data pro-
vide a molecular explanation of how small GTPases act to
regulate Cx43 transport through the secretory pathway,
facilitating or abolishing cell–cell communication through
gap junctions.
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Abbreviations
ARF1 ADP-ribosylation factor-1
Cx43 Connexin-43
ER Endoplasmic reticulum
ERES ER exit sites
FLIM Fluorescence lifetime imaging microscopy
FP Fluorescent protein
FRET Fluorescence resonance energy transfer
IP3 Inositol 1,4,5-trisphosphate
ns Nanoseconds
PIP2 Phosphatidylinositol (4,5)-bisphosphate
PM Plasma membrane
Introduction
Connexins are expressed in complex tissue-speciﬁc and/or
overlapping patterns in most vertebrate cells, including
both neurons and glia in the brain. Two hemichannels from
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DOI 10.1007/s00418-009-0617-xcontacting cells are assembled at the cell–cell interface to
form a gap junction. Gap junctions provide electrical,
energetic and functional connectivity via the passage of
K
?,N a
?,C l
-, and Ca
2? ions, ATP, cAMP, cGMP, IP3,
and other molecules \1 kDa (Bozhkova et al. 1974;
Chailakhyan 1976; Chailakhyan 1990; Loewenstein 1981;
Kumar and Gilula 1996; Goldberg et al. 1999). At least 21
connexin isoforms exist in humans (Willecke et al. 2002;
Sohl et al. 2004). Major regulation of connexin-based
connectivity is thought to occur via the opening and closure
of gap junction channels at the plasma membrane (PM).
However, living cells constantly synthesize and degrade
connexins and thus gap junction coupling is rapidly regu-
latable by many factors (including extracellular cues)
already in membrane trafﬁc pathways at the different
transport steps such as endoplasmic reticulum (ER) exit,
trafﬁc to the PM, and internalization/degradation. How are
connexin expression, degradation and transport to/from the
PM regulated in different tissues and organs? Efforts of
many groups are directed to answer these and related
questions.
In this study, we used a combination of live cell
approaches to analyze transport of Cx43 from the ER to
the PM, with emphasis on small GTPases acting in the
secretory pathway. Sar1 is the small GTPase of the COPII
complex which controls transport of transmembrane and
lumenal cargo via ER exit sites (Dascher and Balch 1994;
Kuge et al. 1994; Aridor et al. 1995; Bonifacino and Glick
2004). COPII-mediated transport of several transmem-
brane receptors has been shown to involve 14-3-3 family
members (O’Kelly et al. 2002; Yuan et al. 2003; Coblitz
et al. 2005). However, the cellular functions of these
interactions remain unclear. In proteomics screens from
brain fractions we routinely obtained 14-3-3 family
members as interactors for the C-terminal tail of Cx43
fused to GST. Different 14-3-3 isoforms were shown to
interact with integral transmembrane proteins, such as
GABAB receptors (Couve et al. 2001) and potassium
channel subunits (Rajan et al. 2002). 14-3-3 machinery has
been suggested to regulate the cell surface expression of
NMDA and AMPA receptors (Xia et al. 2001). Cx43
harbors at its cytosolic C-terminus serine repeats that are
potential 14-3-3 binding sites (i.e. when these sequences
are phosphorylated). Interestingly, the serine repeat region
at the Cx43 C-terminus is followed by a RPR motif. RxR-
type sequences have been shown to act as an ER retention
signal in KATP channel subunits (Zerangue et al. 1999).
Similar to KATP channel subunits, truncation of this
potential retention signal in the Cx43D257 mutant leads to
increased cell surface appearance, suggesting that the
C-terminus is involved in regulating Cx43 transport and/or
ER retention.
The fact that ER exit of Cx43 can be blocked by dom-
inant-negative Sar1 was described (Thomas et al. 2005),
and also shown by us (Butkevich 2004). But these studies
did not discriminate speciﬁc actions of the GTP- versus
GDP-restricted forms of Sar1 on the state of Cx43. Second,
a paper from the Warn-Cramer group demonstrated 14-3-3
interactions with a Cx43 C-terminal motif, using in vitro
binding studies and a detailed in silico reconstruction based
on the 14-3-3 crystal structure and modeled Cx43 C-ter-
minal peptides (Park et al. 2006). However, a cellular link
between all three partners—Sar1, 14-3-3 molecules and
Cx43 and the potential role of the RPR sequence in Cx43
transport remained obscure. Cx43 transport from the ER
and its oligomerization into hexameric hemichannels has
been addressed in work of the Musil group (Musil and
Goodenough 1990; VanSlyke et al. 2009), and the Koval
group (Maza et al. 2005). Both approaches were based on
cross-linking experiments and subcellular fractionation and
the data suggested that Cx43 oligomerization may occur
during ER exit or shortly thereafter, or in some cases as late
as in the trans-Golgi. Here, we combined ﬂuorescence
microscopy analyses, FLIM-FRET, cryo-electron micros-
copy and immunodetection to discriminate effects of dif-
ferent mutants of small GTPases on Cx43 transport and
Cx43 oligomerization in living cells.
Materials and methods
Cell culture, molecular biology and transfection
of Vero cells
Vero cells (Green monkey kidney ﬁbroblast cells) and
primary rat astrocytes were grown at 37Ci nD M E M
medium supplemented with 10% fetal bovine serum (FBS),
2 mM glutamine, 100 U/ml penicillin and 100 lg/ml
streptomycin in 10% CO2; 100 lg/ml G418 was added to
transfected Vero cells in case of selection for stable
transfectants. All cells were transfected by electroporation
as described previously (Butkevich et al. 2004; Majoul
et al. 2006), and plated on poly-D-lysine-coated 25 mm
coverslips (Menzel, Germany). For transfection, cells were
washed with 29 PBS and transferred into electroporation
media. Fluorescent fusion proteins were constructed using
the pEGFP, pEYFP or pECFP vectors (Clontech, Palo Alto,
CA, USA). cDNAs encoding isoforms of 14-3-3 (epsilon
and beta) were isolated from a mouse brain library
(Clontech) by PCR ampliﬁcation, and subcloned into either
pEGFP-N1 or pcDNA3. Carboxy terminally tagged
Cx43-FPs were described earlier. Electrophysiological
characteristics of FP-tagged Cx43 variants were indistin-
guishable from the untagged proteins (Butkevich et al.
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1232004). Expression clones for dominant-negative Arf6 and
Sar1 mutants were kind gifts from Dr. J. Donaldson (NIH)
and Dr. B. Balch (Scripps), respectively. The Lgp120-GFP
clone was a kind gift from P. Luzio (Cambridge, UK).
Anti-Cx43 antibodies raised against the carboxy terminal
tail peptide were afﬁnity puriﬁed by chromatography using
peptide coupled to CNBr-activated Sepharose. The speci-
ﬁcity of the Cx43 C-terminal antibody was conﬁrmed with
peptide-blocking Western blots and immunoprecipitations.
The following commercial antibodies were used: anti-pan
14-3-3 (Chemicon) and an isoform-speciﬁc anti-14-3-3
antibody (Santa Cruz); anti-GST (Santa Cruz), mouse anti-
HA (Sigma), chicken anti-HA-HRP (Abcam), mouse anti-
GFP (Chemicon, Upstate), and rabbit anti-GFP (Abcam).
Electron microscopy of ultra-thin cryo-sections
by Tokuyasu
Vero cells grown in cell culture dishes were directly ﬁxed
with 2% PFA and 0.1% glutaraldehyde in 0.1 M PBS pH
7.4 for 30 min at room temperature. After removal of the
ﬁxation solution, cells were post-ﬁxed with 4% PFA and
0.1% glutaraldehyde for 2 h on ice. Ultrathin cryo-sections
were prepared according to Tokuyasu (1978). After
washing with PBS, cells were embedded in 10% gelatine,
cooled on ice and cut into blocks that were infused with
2.3 M sucrose at 4C and stored in liquid nitrogen. Ultra-
thin cryo-sections were cut at -110C using a diamond
knife (Diatome) in an ultracryomicrotome (Leica), col-
lected into a 1:1 mixture of 1.8% methyl-cellulose and
2.3 M sucrose. For immunolabeling, sections were incu-
bated with anti-Cx43 or anti-drebrin antibodies for 1 h
followed by a 30 min incubation with 10 or 5 nm colloidal
gold-labeled goat-anti-rabbit or goat-anti-mouse Fabs
(British BioCell) or protein A-Gold as described by us
earlier (Butkevich et al. 2004). Images of sections were
acquired with a Philips CM120 electron microscope.
Subcellular fractionation of Vero cells
Subcellular fractionation of Vero cells was performed
essentially as described (Majoul et al. 1996). ER, PM and
Golgi fractions were sedimented at 120,0009g to obtain
samples for SDS-PAGE analysis of proteins. Fractions
containing Golgi membranes were recognized using an
enzyme assay for UDP-galactosyltransferase, ER fractions
were detected with rotenone-insensitive cytochrome
C-reductase, and anti-KDEL-sequence antibodies (Majoul
et al. 1996; Butkevich et al. 2004). Immunoprecipitates
from ER or Golgi fractions were resolved by SDS-PAGE,
blotted to nitrocellulose and immunoprobed with com-
mercial anti-Cx43 antibodies, or home-made anti-Cx43
antibodies raised against the C-terminal peptide.
Confocal microscopy and image analysis
Plasmids encoding Cx43-CFP, Cx43-GFP, and Cx43-YFP
were introduced into Vero cells by electroporation. These
ﬂuorescent chimeras are transported to the PM where they
form functional gap junction channels. Earlier, using dual
patch clamp and electrophysiology we showed that FP-
tagged Cx43 has similar properties as wild-type Cx43
(Butkevich et al. 2004). Routinely we obtain 60–80% of
cells expressing ﬂuorescent chimeras using an optimized
transfection protocol described earlier (Majoul et al. 2006).
To image ECFP, EGFP, or EYFP- tagged Cx43 we used
different modes of an Olympus FV1000-based confocal
setup. Brieﬂy, internal laser lines at 440, 488, 514, or
543 nm, or an external 532 nm laser were used to excite
FPs. In some cases we used a Cascade CCD camera
attached to the base port of an IX81 microscope and the
illumination derived from a Xenon lamp was reﬂected
using a specially coated dichroic mirror (Z488RDC;
Chroma Technology) and passing through a high-numeri-
cal aperture objective (639, NA 1.40, or 1009, NA 1.4,
Olympus, Melville, NY). Fluorescence emitted from the
tagged proteins passed through narrow Semrock ﬁlter sets
for ECFP, EGFP and YFP (http://www.laser2000.co.uk/
semrock/brightline.htm), except for CFP emission, where a
BP 485/17 nm Omega Optics ﬁlter was used. Emission
light was collected by a cooled-CCD (ORCA ER II;
Hamamatsu, Bridgewater, NJ, USA). Cells grown on
25 mm Menzel glass coverslips were placed in a custom-
made chamber and imaged at 25–37C. Several represen-
tative cells were recorded for each condition with the same
intensity settings and averaged for standard error determi-
nation. After transfection with a Cx43-FP encoding plas-
mid cells were plated at high or low densities (10
5 or 10
7
cells, respectively) to study transport of Cx43 in cells with
or without cell–cell contacts. Transfected cells were ana-
lyzed for transport of CX43-FP at different time points
after transfection, from 4 to 12 h, as indicated.
FRET-FLIM measurements and image analysis
FRET-Fluorescence Lifetime Measurements (FLIM) were
performed by wide-ﬁeld frequency-domain FLIM micros-
copy, using a Lambert Instrument FLIM setup (http://www.
lambert-instruments.com) attached to an Olympus IX70
microscope. An Argon-Ion laser, intensity-modulated at
75 MHz, was used as the excitation source and images were
recorded with a CCD camera using an image intensiﬁer,
which was also modulated at 75 MHz. FLIM sequences
were obtained using a 409 and 639/1.4 numerical aperture
(NA) oil objectives. CFP was excited with a 440-nm Argon
laser line and ﬂuorescence was detected using CFP-YFP
FRET ﬁlters(http://www.laser2000.co.uk/semrock/fret.htm).
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123Phases of the emitted ﬂuorescence were calculated from the
resulting set of images. Vero cells were imaged also by
conventional wide-ﬁeld ﬂuorescence microscopy, to esti-
mate the relative intensity of the Golgi ﬂuorescence. Two
different populations of Cx43 molecules were thus
resolved: one that exhibits FRET and another that does not,
based on the measured phase shift (phase lifetime or sf).
Images were analyzed using the MetaMorph 7.1 pro-
gram (Universal Imaging, West Chester, PA, USA) with a
FRET calculation program. For ﬁnal presentation all ima-
ges were transferred into Adobe Photoshop CS2. The
IgorPro mathematical program was used for statistical
calculations of data acquired using MetaMorph 7.1.
Results
Cx43 exit from the ER is blocked by both GTP-
and GDP-restricted forms of Sar1, but only Sar1-GTP
induces accumulation of 14-3-3 proteins in the ER
To analyze the effect of small GTPases on Cx43 transport
we standardized transfection and live cell analysis proto-
cols. Fast appearance of newly formed Cx43-FP gap
junctions starts to be detectable 2–4 h after transfection.
Both ﬂuorescence microscopy and electron microscopy
data demonstrate that presence of contacts between cells
facilitates the formation of Cx43 positive double-mem-
branes, i.e. gap junctions (Fig. 1). On the other hand,
absence of cell–cell contacts prevents this polarized accu-
mulation of connexins at the PM and is accompanied by
early accumulation of Cx43-FP in perinuclear lysosomal
structures (Fig. 1a–d, arrows).
One of the requirements for fast cell–cell contact for-
mation is the ability of Cx43 to leave the ER. Here, we
blocked ER exit by expression of GTP-restricted Sar1,
Sar1H79G, or GDP-restricted Sar1, Sar1T39N, and show
that ER exit and appearance of Cx43 at the cell–cell inter-
face is prevented with either mutant (Fig. 1g). Classical
Tokuyasu ultrathin cryosections of Vero cells transfected
with Cx43-GFP (12 h) and probed with anti-GFP antibodies
revealed typical gap junction double-membranes between
two contacting cells (Fig. 1e; note absence of ER labeling
for Cx43 around the nucleus). Both anti-Cx43 and anti-GFP
antibodies enabled detection of transfected Cx43-GFP with
protein A-gold. In contrast, cryosections of Vero cells
co-transfected with Cx43-GFP and Sar1H79G show strong
accumulation of Cx43 in the perinuclear ER region rich in
vesicular–tubular extensions (Fig. 1f). Typical double
membranes with Cx43 reactivity were not found in cells
co-transfected with either Sar1 mutant. These results con-
ﬁrm our live cell data that Cx43-GFP remained in the ER
and failed to accumulate at the cell–cell interface. Sar1 acts
in the early secretory pathway as part of the COPII coat
complex. To visualize the COPII coat we used two COPII
subunits, Sec13-GFP and Sec23-YFP, co-transfected with
either Sar1H79G or Sar1T39N.Accumulationof Cx43-GFP
in COPII-positive ER exit sites was seen only in cells
co-transfected with Sar1H79G.
To further analyze morphological differences caused by
Sar1 mutants we used biochemical analyses and subcellular
fractionation of cells co-transfected with either Sar1H79G
and Cx43-FP or Sar1T39N and Cx43-FP. ER and Golgi
fractions were separated from the cytosol and PM by
fractionation and tested for enzymatic activity: Golgi—
UDP-Gal-Transferase, ER—Rotenon-Insensitive Cyto-
chrome C-Reductase are overlayed with decreasing total
protein concentration as described earlier (Butkevich et al.
2004). Combined ER fractions 7 and 8 were resolved by
SDS-PAGE and immunoprobed with anti-Cx43 and Pan-
14-3-3 antibodies. Figure 2i shows the following: lane 1:
ER fraction from cells co-transfected with Cx43-FP and
Sar1T39N, lane 2: control Golgi fraction, lane 3: ER
fraction from cells co-transfected with with Cx43-FP and
Sar1H79G, lane 4: cytosol as a positive control for 14-3-3.
Under these conditions we detect accumulation of 14-3-3
only in the ER fraction from Vero cells co-transfected with
Sar1H79G and Cx43 (lane 3) but not from cells co-trans-
fected with SarT39N and Cx43-FP (lane 1). Time-depen-
dent accumulation of 14-3-3 proteins after co-transfection
of Cx43-FP and Sar1H79G in the ER fraction is observed
(see Fig. 2m, n). As a further control we used an ER
fraction isolated from cells transfected with Sar1H79G
alone. Here, in the absence of Cx43-FP, we do not see
accumulation of 14-3-3 immunoreactivity (Fig. 2i–1). A
likely explanation for this result is that Vero cells express
only low levels of endogenous Cx43 (compare to Cx43
transfected cells in which Cx43 expression may be
increased up to tenfold, as estimated by immunoblot) and
none of the neuronal receptors described to bind 14-3-3.
Our interest in 14-3-3 as a potential binding partner for
Cx43 was triggered when we noticed a non-canonical 14-3-3
binding motif and consensus serine phosphorylation sites at
the very C-terminus of Cx43 (Fig. 2e). Second, we
repeatedly recovered 14-3-3 proteins from mice and rat
brain extracts with Cx43 C-terminus fused to GST in pull-
down assays followed by proteomics analysis. The Cx43
sequence predicts that it can be phosphorylated in its
cytosolic C-terminal domain and approximately ten dif-
ferent kinases have indeed been demonstrated to phos-
phorylate Cx43 (Herve et al. 2007). The crystal structure of
14-3-3 proteins suggests the binding for two phosphory-
lated molecules (reviewed in Fu et al. 2000). Thus, 14-3-3
proteins may assist lateral dimerization of Cx43 and for-
mation of connexin hexamers already in the ER membrane
or upon ER exit. Interestingly, Sar1T39N not only
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123prevented segregation of Cx43 into ER exit sites but also
increased Cx43 degradation (Fig. 2j, see lower bands in
lane 1). Likely, Cx43 is directed for ER-associated degra-
dation when unable to leave the ER. Note that the same
blot was re-probed with anti-14-3-3 antibodies to detect
accumulation of 14-3-3 (Fig. 2k). Unfortunately, ﬂuores-
cence imaging of the distribution of 14-3-3 proteins in
single cells could not resolve the Sar1H79G-induced 14-3-
3 accumulation on ER membranes, as both the available
antibodies against 14-3-3 and 14-3-3-FP after transfection
gave a strong cytosolic staining against which background
the ﬁne ER membrane structures could not discerned. In
contrast, 14-3-3 and Cx43 readily colocalize at non-con-
tacting membranes of double-transfected cells (Fig. 4l–m).
Even more surprising was the complete absence of 14-3-3
from the cell–cell interface, where Cx43 is readily
detectable (see Fig. 4o–p). The intensity scan in Fig. 4q, r
(arrow) indicates Cx43 accumulation at the cell–cell
interface. We do not know how long the Cx43/14-3-3
complex may persist as a transport intermediate after ER
exit, but hypothesize that during gap junction formation at
the PM other binding partners such as submembrane
cytoskeleton proteins (e.g. drebrin or ZO1) may displace
14-3-3 from the Cx43 tail.
Oligomerized states of Cx43 in ER exit sites resolved
by FRET-FLIM microscopy in living cells
First, to conﬁrm that Sar1H79G blocks Cx43 in ER exit
sites (ERES) we co-expressed two subunits of the COPII
complex, Sec13 and Sec23, with Cx43. In triple-transfected
cells expressing Sar1H79G Cx43 colocalized with both
Fig. 1 Analyses of Cx43 assembly and exit from the ER. Vero cells
were transfected with Cx43-CFP and analyzed for Cx43 transport at
different time intervals after transfection (4–12 h). In contrast to non-
contacting cells (a–d), activity-dependent transport of Cx43 to the PM
is facilitated by the presence of cell–cell contacts (e). Sar1H79G
blocks Cx43 exit from the ER (g, f, h) and prevents formation of gap
junction plaques (g). In the absence of cell–cell contacts Cx43 from
the Golgi pool is delivered to distinct perinuclear dots (a–d), that can
be later colocalized to the lysosomal markers (see further Fig. 6).
e Classical Tokuyasu ultrathin cryosections of Vero cells transfected
with Cx43-GFP (12 h) were probed with anti-GFP antibodies
(Invitrogen), followed by protein A-gold detection (PAG; 10-nm
gold). Typical gap junction plaque between two contacting mem-
branes is shown; f Ultrathin cryosections (Tokuyasu) of Vero cells co-
transfected with Cx43-GFP and Sar1H79G reveal an ER localization.
Cells were ﬁxed 12 h after transfection and probed with anti-GFP
antibodies (PAG; 10-nm gold). In contrast to control cells (e),
immuno-EM analysis of cells expressing Cx43-GFP and Sar1H79G
(f) reveals strong accumulation of Cx43 in the perinuclear ER region.
g, h In double-transfected cells Sar1H79G blocks exit of Cx43-GFP
from the ER and connexins fail to accumulate at the cell–cell
interface (g, arrow); compare to control cells transfected only with
Cx43-GFP (e). Scale bar 200 nm for EM and 10 lm for ﬂuorescence
microscopy images
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123Fig. 2 a–h Two distinct states of Cx43 in the ER in Vero cells
expressing Sar1T39N or Sar1H79G. Only Sar1H79G accumulates
Cx43 in ER exit sites (ERES) (h). This state correlates with
accumulation of 14-3-3 molecules in the ER fraction (see k).
a–c Cx43-GFP in cells co-transfected with Sar1T39N remains in the
ER membranes, does not segregate into exit sites and does not
co-localize with the COPII coat (c, overlay). d Immuno-EM analysis
of ultrathin cryosections of Vero cells co-transfected with Cx43-GFP
and Sar1T39N probed with anti-GFP antibodies and protein A-10 nm
gold revealed that Cx43 immunoreactivity was distributed evenly
along an extended ER network and not concentrated in the charac-
teristically rounded ERES. A region of interest (Ins 1) is shown
enlarged. e Cx43 transmembrane topology and acid sequence at the
cytosolic C-terminus of Cx43 harboring serines in a context suitable
for phosphorylation, 14-3-3 protein interaction and RPR/COPI binding
motifs. f–g Sar1H79G induces colocalization of Cx43 with the Sec13
subunit of the COPII coat. h Tokuyasu cryo-sections of Vero cells co-
transfected with Cx43-GFP and Sar1H79G. Immunogold staining with
anti-GFP antibodies show ER cisternae and clearly detectable rounded
ERES structures that are decorated with Cx43-GFP. A region of
interest showing Cx43 concentrated in ERES is shown (Ins 2).
Co-localization between Cx43 and the COPII subunit Sec13-YFP is
increased in cells co-expressing Sar1H79G (f–g). i Subcellular
fractionation of monolayer-grown Vero cells. ER and Golgi fractions
were separated from the cytosol and PM fractions and tested for
enzymatic activity: UDP-Gal-Transferase for the Golgi; Rotenon-
Insensitive Cytochrome C-Reductase for the ER. Total protein
concentrations in the fractions are indicated. j–k Proteins from
combined ER fractions 7 and 8 (i) were resolved by SDS-PAGE and
immunoblotted with anti-Cx43 and Pan-14-3-3 antibodies. Lanes are
as follows: 1 ER fraction of cells transfected with Sar1T39N, 2 control
Golgi fraction, 3 ER fraction of cells transfected with Sar1H79G, 4
cytosol. ER fractions (7–8 of the gradient, i) usually show upper
oligomeric bandsof Cx43 (j) with the Cx43 antibodies; these bandsare
absent in the cytosol fraction (j, lane 4)( k). Note that 14-3-3
accumulation is observed only in the ER fraction of cells transfected
with Sar1H79G. 14-3-3 proteins are abundantly present in cytosol,
used as a positive control. l Vero cells transfected with Sar1H79G
alone do not show accumulation of 14-3-3 immunoreactivity in the ER
(l, 1). Accumulation of 14-3-3 proteins in the ER fraction is seen only
in cells co-transfected with Cx43 and Sar1H79G (l, 2). m–n Time-
dependent accumulation of 14-3-3 proteins in the ER fraction of Vero
cells co-transfected with Cx43 and Sar1H79G (4–10 h). The same
membrane was reprobed with anti-tubulin as a loading control
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123Sec13 (Fig. 2f–g) and Sec23 (Fig. 3b, d). Second, we used
Vero cells stably expressing p23-CFP to show that ER exit
sites are structures different from dispersed Golgi stacks, as
Sar1H79G also prevents transport of Golgi resident pro-
teins from the ER. The transmembrane Golgi protein p23
normally resides in Golgi stacks (Fig. 3a). In cells co-
transfected with Cx43-GFP, Sec23-YFP and Sar1H79G
Cx43 is found in punctate structures representing ER exit
sites and partially colocalize with the dispersed structures
labeled by p23-CFP (Fig. 3).
To better understand the state of Cx43 in dispersed,
COPII positive ER exit structures we applied FRET-FLIM
analysis of living cells. Generally, it is agreed that Cx43
exists in assembled hexameric form in the Golgi and Cx43
readily accumulates in the Golgi region during time-
dependent transport after transfection. Here, we used FRET
between Cx43-CFP (donor) and Cx43-YFP (acceptor) to
obtain control FLIM lifetime data for the oligomerized
form of Cx43. Indeed, although the total ﬂuorescence of
Golgi structures viewed in conventional microscope
appeared bright (Fig. 3f), the lifetime of the Cx43-CFP
donor was shortened [see color coding in red (2.6 ns) and
blue (1.8 ns) in Fig. 3e]. As derived theoretically and
shown experimentally, FRET can occur only at a molecular
distance range of 3–7 nm. Ro for the CFP- and YFP-pair is
known to be 49–52 A ˚ (Tsien 1998; Miyawaki and Tsien
2000). As revealed by the crystal structures of Cx43 (Unger
et al. 1999) and GFP (Yang et al. 1996), this close prox-
imity may occur only if Cx43 is in its hexameric oligo-
merized state. To measure FRET in living Vero cells we set
up lifetime FLIM measurements of the donor, Cx43-CFP,
in the presence or absence of the acceptor, Cx43-YFP.
Control Vero cells co-expressing this Cx43-CFP/Cx43-
YFP FRET pair revealed a strong and signiﬁcant decrease
in the Cx43-CFP lifetime in the Golgi region, where donor
lifetime was decreased from 2.5 ± 0.19 to 1.9 ± 0.13 ns
(Fig. 3e–f). Cx43-CFP co-expressed with Sar1H79G did
not show a Golgi accumulation, as expected. Instead, Cx43
Fig. 3 Oligomerization of Cx43 resolved in living cells using FRET-
FLIM analysis. ER-to-Golgi transport of oligomerized Cx43 requires
COPII and functional dynein motor complex. a p23-CFP stably
expressed in Vero cells shows a typical Golgi pattern. Such cells were
used for further transfection with Cx43-GFP, Sar1H79G and Sec23-
YFP (a–d). The cell in the center (a) expresses all four constructs.
b Cx43 is blocked in ER exit sites by Sar1H79G which also blocks
p23 transport from the ER and thus prevents its Golgi accumulation
(middle cell, a). Cx43 co-localizes with the COPII component Sec23-
YFP (d). c Composite overlay of three channels: CFP, GFP and YFP.
The ﬂuorescence of the three channels was resolved by linear signal
unmixing on the FV1000 confocal microscope. The overlay shows
that in Sar1H79G expressing cells Cx43-GFP colocalizes with Sec23-
YFP in ERES (resolved by EM in Fig. 2h), while the Golgi protein
p23-CFP cannot be detected in the Golgi and is dispersed in the ER
membrane. e–h Fluorescence Life Time Microscopy (FLIM) mea-
surements in Vero cells co-expressing the Cx43-CFP/Cx43-YFP
FRET pair. e Control cells (expressing no Sar1H79G) co-transfected
with the donor/acceptor pair Cx43-CFP and Cx43-YFP show
accumulation of both ﬂuorescence signals in the Golgi region.
Analysis of the distribution of lifetime (s, given in nanoseconds) in
the Golgi region reveals a strong decrease of s. Lifetime was
diminished from 2.5 to 1.9 ns as a result of FRET induced by close
proximity of donor/acceptor proteins, due to oligomerization and
segregation of connexins. f Wide-ﬁeld microscopy image conﬁrming
strong accumulation of Cx43-FP in the Golgi region. g, h In cells co-
transfected with the Cx43-CFP/Cx43-YFP donor/acceptor pair and
Sar1H79G, Cx43-FP fails to arrive to the Golgi and instead appears in
perinuclear dots corresponding to ERES (for comparison see EM
images of ERES in Fig. 2h). h The Cx43-FP labeled perinuclear
structures display a similar decrease of ﬂuorescence lifetime (2.3–
1.8 ns) as those seen in the control Golgi region (g), as a result of
FRET. i–l ER–to-Golgi trafﬁc of Cx43 utilizes the microtubule-based,
minus-end directed dynein motor complex. i Overexpression of p50-
CFP, the dynamitin subunit of the dynein/dynactin complex, blocks
ER-to-Golgi transport of Cx43-YFP, (j); in such cells Cx43 is unable
to enter the cis/medial-Golgi detected with antibodies against KDEL-
receptor (k). The overlay (l) shows absence of colocalization for Cx43
with the cis/medial-Golgi marker KDEL-receptor
b
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123accumulated in ER exit sites, where it co-localized with the
COPII subunit Sec23-YFP (Fig. 3d). FLIM measurements
obtained from Vero cells co-transfected with Sar1H79G
and the Cx43-CFP/Cx43-YFP FRET pair revealed a sig-
niﬁcant decrease in ﬂuorescence lifetime of Cx43-CFP (tau
measured with this setup was reduced from 2.5–2.3s to
1.9–1.7 ns as a result of FRET between CFP- and YFP-
molecules in close proximity (Fig. 3). In fact, a very sim-
ilar decrease of the Cx43-CFP lifetime was observed in the
Golgi region of control cells (Fig. 3e) and in ER exit
sites when Cx43 transport was blocked by SarH79G
(Fig. 3g–h). These data obtained in living cells conﬁrm that
Cx43 is present in oligomerized form in both structures: in
the Golgi region in control cells and in ER exit sites in cells
transfected with Sar1H79G.
Exit of oligomeric Cx43 from the ER requires an intact
dynein motor complex
Cx43 transport from the ER to the Golgi involves micro-
tubules and the application of nocodazole has been shown
to disrupt Cx43 transport (Giepmans et al. 2001). Micro-
tubule-dependent ER-to-Golgi transport is regulated by the
minus-end-directed dynein motor (Burkhardt et al. 1997).
Here, we overerexpressed the p50-CFP subunit of the
dynactin complex, known to disrupt ER-to-Golgi transport
(Valetti et al. 1999). In p50-CFP-transfected cells Cx43-
YFP remained in ER exit sites and the ER/Golgi interme-
diate compartment, ERGIC (Fig. 3i–j). Cx43-YFP co-
expressed with p50-CFP failed to colocalize with the
KDEL-receptor which resides in the cis- and medial-Golgi
(Fig. 3k). These data suggest that although Cx43 exists in
its oligomeric form, p50 disrupts the interaction of Cx43
vesicles with microtubular dynein motor components and
prevents vesicle transport and/or formation.
Overexpression of b-COP, a subunit of the COPI coat,
inhibits Cx43 transport
The COPI coat is localized to Golgi membranes, where it
drives the budding of transport vesicles that mediate Golgi-
to-ER retrieval and intra-Golgi trafﬁc. The coat minimally
consists of the small GTPase Arf1 and the heptameric
coatomer complex (a-, b-, b0-, c-, d-, e-, and f-COP) and
disassembles after vesicle formation in preparation for
membrane fusion (reviewed in Duden 2003). Little is
known about the role of the cytosolic pool of individual
COPI subunits. The Cx43 C-terminus harbors a COPI
binding motif (RPR) directly after the 14-3-3 binding motif
(Fig. 2e, sequences). In Vero cells overexpressing b-COP
tagged with CFP (Fig. 4i) Cx43 remained in the ER
(Fig. 4j, k). In contrast, a cell (on the left in Fig. 4j, k)
separately transfected with Cx43 alone and then co-plated
with cells double-transfected with Cx43-YFP and b-COP-
CFP shows nice accumulation of Cx43 at the cell–cell
interface (Fig. 4k, arrow). As discussed above, the Cx43
C-terminus contains two almost overlapping protein inter-
action motifs, a potential 14-3-3 binding site with a serine
phosphorylation consensus and a RPR sequence. RxR
motifs have been shown using the two-hybrid system to
interact with b- and d-COP (Michelsen et al. 2007). It is
conceivable that a balance of 14-3-3 and the monomeric
b-COP pool is used by the cell for ﬁne tuning of Cx43 exit
to the PM- versus ER-associated degradation. Arginine-
based COPI binding motifs were shown to act as a ER
retention signal for other multisubunit protein complexes
such as GABAB G-protein coupled receptors (Margeta-
Mitrovic et al. 2000) and the NMDA receptor splice variant
NR1 (Standley et al. 2000; Scott et al. 2001). COPI binding
acts to prevent the cell surface appearance of both neuronal
receptors. Taken together these data lead to the hypothesis
that recognition of arginine-based signals for ER retention
of neuronal receptors and Cx43 share a common mecha-
nism in higher eukaryotic cells.
The long-lived COPI/coatomer complex (with a mea-
sured half-life of *28 h once assembled; Lowe and Kreis
1996) is composed of seven stoichiometric subunits.
Therefore, the b-COPI-CFP subunit when expressed in
cells for 10–12 h is incorporated into coatomer only to a
limited degree. Nevertheless, 10–15% of transfected cells
revealed a clear Golgi staining for b-COP-CFP, thus
allowing for statistical analysis of effects on Cx43 trans-
port. Surprisingly, we ﬁnd that not only Golgi–PM trans-
port of Cx43-YFP was blocked in cells expressing b-COP-
CFP but also ER exit of Cx43 is impaired, demonstrating a
novel dominant-negative effect of b-COP overexpression
on protein transport in the secretory pathway.
GTP-restricted Arf1 blocks Cx43 in the Golgi
and prevents formation of gap junction plaques
We further analyzed processing of Cx43 on the way to the
PM. Normally Cx43 accumulates in the Golgi complex,
where a master regulatory switch for entry and exit of
protein cargo, the small GTPase Arf1, operates. Arf1 is a
component of the coat of COPI vesicles that mediate
Golgi-to-ER retrieval and intra-Golgi trafﬁcking. Arf1 is a
very weak GTPase by itself and thus requires ARF-GTPase
activating proteins (ARFGAPs) for its functional cycle, of
which three different isoforms ARFGAP1-3 are expressed
in mammalian cells that together perform essential func-
tions (see Frigerio et al. 2007). Cx43-CFP when co-
expressed with wild-type Arf1-YFP rapidly formed gap
junctions in contacting Vero cells (Fig. 4a, b), similar to
contacting control cells (data not shown). In the presence
of cycloheximide Cx43 was localized mainly at the PM
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123Fig. 4 Arf1Q71L prevents formation of gap junction plaques and
blocks Cx43 exit from the Golgi. Effects of expression of b-COP and
14-3-3 expression on Cx43 transport to the Golgi. a–b Cx43-CFP
co-expressed with wild-type Arf1-YFP in Vero cells. Contacting cells
form gap junctions (indicated by arrows). In the absence of
cycloheximide Cx43-CFP can be seen in the ER, Golgi and at the
PM. c–d In cells expressing Arf1Q71L, Cx43-CFP fails to form gap
junction plaques at the PM. e, f Cells co-expressing Cx43-CFP and
wild-type Arf1-YFP and treated for 1 h with cycloheximide before
imaging display Cx43 only at the PM (arrows Cx43-CFP at the cell–
cell interface). g, h Cx43-CFP accumulates in the Golgi in cells
co-expressing Arf1Q71L. A cell–cell contact region depleted of Cx43-
CFP is indicated by arrow in g. Cells were treated for 1 h with
cycloheximide. i, j Expression of b-COP-CFP results in a strong block
of ER-to-Golgi transport of Cx43-YFP. k Enlarged overlay of the two
channels. An ER distribution for Cx43 is observed in the cell to the
right that expresses b-COP-CFP. In contrast, the cell on the left
transfected only with Cx43-YFP shows a PM labeling for Cx43 at a
cell–cell contact site (arrow). l, m, n 14-3-3 colocalizes with Cx43 at
the edge of non-contacting PM regions in co-transfected cells. o–p In
cells co-transfected with Cx43-CFP and 14-3-3e-YFP, 14-3-3 reac-
tivity never accumulates at the contacting cell–cell interface. How-
ever, the two proteins do co-localize in the Golgi (arrows). q Absence
of 14-3-3e at the cell–cell interface revealed by ﬂuorescence intensity
distribution; r In contrast, in the same cell Cx43 is clearly visible seen
at the PM interface with a contacting cell (arrow)
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123(Fig. 4e, f), as both the ER and Golgi pools were rapidly
cleared by transport to the PM. In contrast, in cells co-
expressing the GTP-restricted ARF1, Arf1Q71L, Cx43-
CFP failed to leave the Golgi and gap junction plaques
were absent between contacting cells (Fig. 4c, d, g, h). Our
data thus conﬁrm that both the COPI complex and the
small GTPase Arf1 are involved in Cx43 transport.
GTP-restricted Arf6 reduces the size of gap junction
plaques and facilitates Cx43 degradation via a non-
lysosomal pathway
The small GTPase Arf6 is involved in trafﬁc in between the
PM and endosomes. However, precisely how the activation
of Arf6 regulates vesicular transport remains unknown. We
here demonstrate a strong reduction of Cx43-positive cell–
cell interfaces in Vero cells upon expression of a GTP-
restricted Arf6 mutant, Arf6Q67L (Fig. 5a). Control cells
transfected with Cx43-GFP alone displayed a normal cell–
cell interface localization for Cx43 (Fig. 5b). Expression of
a GDP-restricted Arf6 mutant, Arf6T44N, did not alter this
localization of Cx43 in gap junctions compared to control
cells (data not shown). Both GFP signals were recorded
10 h after transfection. Statistical evaluations of data
obtained from randomly taken pictures of monolayer-
grown transfected cells conﬁrmed that in cells co-trans-
fected with Arf6Q67L a strong decrease of the gap junc-
tional cell–cell interface occurs. Cx43-GFP gap junction
staining was reduced down to 10% of the level observed in
control cells. The relative decrease in gap junction surface
area induced by Arf6Q67L and mathematical treatment of
the data is shown in Table 1. Inverted black–white images
of Vero cells transfected with Cx43-GFP alone as a control
revealed accumulation of Cx43-GFP at cell–cell interfaces,
in the Golgi region, and in perinuclear lysosomes (Fig. 5c).
In contrast, in cells co-expressing Arf6Q67L a gap junc-
tion-like cell–cell interface typically remained only in
small regions (indicated by arrows in Fig. 5d). Note the
complete absence of Cx43 accumulation in perinuclear
lysosomes in such cells, especially striking when compared
to the lysosomal Cx43 accumulation routinely observed in
control cells (compare Fig. 5a, d vs. b, c). At the cell
periphery Cx43 is partially colocalized with Paxillin in
Arf6Q67L-transfected cells (Fig. 5e–g). The membrane
fractions of control cells (left) and Arf6Q67L-transfected
cells (right) were separated by 10% SDS-PAGE and probed
with anti-Cx43 antibodies. Immunoblot analysis indicated
strong degradation of Cx43 in the membrane fraction from
Arf6Q67L-transfected cells compared to control cells
(Fig. 5h). Using live cell time-lapse microscopy we ana-
lyzed the attempt and failure of Cx43-GFP in cells co-
expressing Arf6Q67L to form gap junction plaques
(Fig. 5i, time interval 7–12 h). As two cells were unable to
align their cell–cell interface, the few remaining gap
junctions dots were degraded. Our results demonstrate that
expression of Arf6Q67L strongly diminishes formation of
Cx43 gap junctions. Furthermore, cells expressing
Arf6Q67L were unable to maintain pre-existing Cx43-GFP
gap junction plaques at the cell–cell interface (data not
shown). A possible explanation of the strong effect of
Arf6Q67L on gap junction formation/maintenance is that
Arf6 facilitates endocytosis, removing newly arrived Cx43-
GFP from junctional contacts (Fig. 5i).
Cx43 redistributes to lysosomes and undergoes
increased degradation in response to cell stress
To address the mechanism of Cx43-GFP disappearance
from the PM in Arf6Q67L-expressing cells we applied
Chloroquine (CLQ) a known inhibitor of lysosomal deg-
radation. Surprisingly, CLQ did not prevent removal and
degradation of Cx43 even at high concentrations (Fig. 6).
On the other hand, a mixture of proteasomal inhibitors
(epoxomicin, MG132, and Lactacystin, each at 5 lM) did
partially restore Cx43-GFP accumulation at the cell–cell
interface (data not shown), suggesting that under the con-
ditions described Cx43 undergoes proteasomal degrada-
tion. In contrast to the effect of Arf6Q67L on Cx43
degradation shown above, cellular stress induced by
exposure of Cx43 transfected cells to high potassium
medium (120 mM without Ca
2? for 2 h) did trigger lyso-
somal degradation. Under this condition we detected
extensive colocalization of Cx43-CFP in ring-like struc-
tures positive for the lysosomal protein Lgp120-YFP
(Fig. 6d–f) compared to control cells (Fig. 6a–c). Image
analysis conﬁrmed that under this stress condition signiﬁ-
cantly less Cx43-FP was present at the cell surface and
more present in lysosomes when compared to control cells.
When we co-expressed Ubiquitin-CFP and Lgp120-YFP
we found that both proteins co-localized in a perinuclear
region and in speciﬁc rings underneath the PM (Fig. 6g–i).
Electron microscopy revealed that these structures repre-
sent multivesicular bodies (data not shown). Ubiquitin-
YFP was frequently found colocalized with Cx43-CFP in
rings (Fig. 6m, n). In contrast, the Golgi protein p23-YFP
did not colocalize with Ubiquitin-CFP or Lgp120-CFP in
co-expressing cells, conﬁrming that the lysosomal and
Golgi pools of Cx43-GFP can be distinguished by light
microscopy (Fig. 6j, k, i, and data not shown). Cx43-CFP
internalized from the non-contacting surfaces of PM co-
localized with Ubiquitin-YFP in ring-like structures
resembling annular junctions. Similar structures were vis-
ible in cells expressing Cx43-GFP upon exposure to Triton
X-100 (Fig. 6p), a treatment known to remove all but
detergent-resistant membrane structures. Interestingly,
lysosomes were not present underneath freshly formed
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123Cx43 plaques (Fig. 6q, r, s), suggesting that lysosomal
degradation involves regulated transport and/or internali-
zation of Cx43 residing in mature gap junctions.
Discussion
Our data presented here demonstrate that Cx43 trafﬁc from
the ER to the PM is strongly regulated by small GTPases.
We analyzed how Cx43 can be blocked in the ER and in
the Golgi complex, or how it can be removed from the PM,
using dominant-negative mutants of the small GTPases
Sar1, Arf1, and Arf6 (summarized in cartoon form in
Fig. 7). We discovered that the GTP- and GDP-restricted
forms of Sar1, Sar1H79G and Sar1T39N, have distinct
effects on the cellular fate of Cx43. Using live cell FRET
analyses, biochemistry, subcellular fractionation and cryo-
immunoelectron microscopy we conﬁrm that only the
GTP-restricted form, Sar1H79G, allows segregation of
Cx43 from the ER membrane into ER exit sites (ERES).
We resolved ERES structures by electron microscopy. A
strong accumulation of Cx43 immunoreactivity in ERES
Fig. 5 Arf6-GTP diminishes formation of Cx43 gap junctions and
facilitates Cx43 degradation. a Formation of gap junction plaques is
strongly reduced in Vero cells co-expressing Cx43-GFP (green) and
Arf6Q67L (not visualized here). The GFP signal was recorded 10 h
after transfection. b Control cells expressing Cx43-GFP alone display
the usual accumulation of Cx43-GFP in gap junctions at the cell–cell
interface at 10 h after transfection. Inverted black–white images (c, d)
more clearly reveal the relative decrease in cell surface area occupied
by Cx43 gap junctions in cells expressing Arf6Q67L. Note absence of
lysosomal accumulation of Cx43 in Arf6Q67L expressing cells (d)
compared to control cells (c). For comparison lysosomal accumula-
tion of Cx43 colocalized with lysosomal markers in control cells is
shown in Fig. 6a–f. e, f, g In Arf6Q67L expressing cells Cx43-GFP
(e) partially colocalizes with Paxillin (f) at the cell periphery (overlay
in g). Note again absence of Cx43 accumulation in characteristic
lysosomal structures. h Membrane fractions of control Vero cells
(left) or Arf6Q67L expressing cells (right) were immunoblotted with
anti-Cx43 antibodies. Strong degradation of Cx43 in the membrane
fraction from ARF6Q67L expressing cells is evident. The upper
(phosphorylated) forms of Cx43 are more resistant to degradation
(indicated by arrowhead). i Time-dependent analyses of cells co-
expressing Cx43-GFP and Arf6Q67L (time interval 7–12 h) reveal
the failure of Cx43 to form gap junction plaques at cell–cell
interfaces. Remaining gap junctions are degraded (compare to cells
expressing Cx43-GFP alone (b–c)). j Diagram of transfection rate and
gap junction formation in control cells expressing Cx43-GFP alone
(yellow bars) and cells co-expressing Arf6Q67L and Cx43-GFP
(violet bars). Note the strong reduction in total gap junction area in
the presence of Arf6Q67L
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where it co-localized with the COPII subunits Sec13 and
Sec23. In contrast, the GDP-restricted mutant Sar1T39N
does not allow segregation of Cx43 into ERES. In such
cells Cx43 remains smoothly distributed along the ER
network. Biochemical analysis revealed that this ‘‘non-
assembled’’ state is accompanied by increased degradation
of Cx43.
Next, we discovered that GTP-restricted Sar1,
Sar1H79G, induces accumulation of 14-3-3 reactivity in
Table 1 Mathematical treatment of data obtained from Arf6Q67L-expressing and control cells reveals a strong reduction of gap junction
contacts induced by Arf6Q67L
Definition of Gap Junction contact area                                                              (A)
Control: Vero cells transfected with Cx43-GFP alone 
Cell surface 
area in µm
2
Total number of cells
              100% 
GJ-contact zone  (% 
of total surface area) 
Nucleus area (%) is 
given for comparison 
 470  +/-(25)  Transfected  65% 3.5%           19%
  Contact formation 25%                    
 Effect of Arf6-GTP on GJ formation:
 Vero cells co-expressing Cx43-GFP and Arf6Q67L
Cell surface area 
       in µm
2
Total number of cells
         100% 
  GJ contact zone 
(%) from surface
Nucleus area (%) is 
given for comparison
 423  +/-(50)  Transfected          38% 1.1%        16.9%
  Contact formation 9%  σ = 0.275           
Results of 5 experiments : Gap junction areas (A1-A5) calculated in µm
2:
A1=1.2; A2= 0.7; A3=0.9; A4=1.2; A5=1.5. Ai= 1.1. M(Ai
2) = 1.286. Dispersion, 
DAi
2=0.076. σΑι=√DAk=√0.076 = 0.275 
We traced the total cell surface area and total gap junction contact areas (A) by selecting regions of interest on ﬂuorescence images. Cell surface
areas and junctional interfaces were calculated using a built-in micrometer. Image data were analysed using MetaMorph 7.1. Transfected cells
similar to the one presented in Fig. 5 were used for analyses. We also measured the area of the nucleus in each cell as a reference zone related to
total cell surface size. Arf6Q67L induces a dramatic decrease in Cx43-GFP gap junction area; this decrease in the gap junction area is
accompanied by an only slight reduction in total cell size as judged by nuclear size
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123Fig. 6 Cx43 transport tothe cell surface anddegradation in lysosomes
in response to mild stress. Vero cells were co-transfected with Cx43-
CFP(a)andthelysosomalmarkerLgp120-YFP(b);imagesweretaken
10 h after transfection via CFP and YFP channels, respectively.
Overlay ofaandbreveals onlypartial colocalization inthe perinuclear
region(c).d–fCellularstressinducedbyexposureoftransfectedcellsto
high potassium medium (120 mM K without Ca
2?) for 2 h redirects
Cx43fromthePMtolysosomes.ExtensivecolocalizationofCx43-CFP
(d) and the lysosomal marker lgp-120-YFP (e) in ring-like, typical
lysosomal structures is seen in the overlay (f). g, h, i In Vero cells co-
expressing Ubiquitin-CFP (g) and Lgp-120-YFP (h) these proteins
colocalize in a perinuclear region and in speciﬁc rings underneath the
PM (i). By EM these structures have the appearance of multivesicular
bodies(datanotshown).j,k,lIncontrast,theGolgiproteinp23-YFP(j)
does not co-localize with Ubiquitin-CFP (k) upon co-expression (see
overlay in l). m, n, o Cx43-CFP internalized from non-contacting PM
areas (m, shown in blue) directly co-localized with Ubiquitin-YFP
(n, shown in yellow) in ring-like lysosomal structures (displayed
enlarged, as red/green overlay, in o). Remarkably, similar types of
structurescanbeobservedafterbrieftreatmentofcellsharboringCx43-
GFPplaqueswithTritonX-100(p),knowntodestroyallbutdetergent-
resistant structures. q, r, s Lysosomes (Lgp120-CFP, q) are not present
underneath freshly formed Cx43 plaques (Cx43-YFP, r), see arrow
pointing to a Cx43-YFP-positive cell–cell contact region
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123the ER fraction in cells co-transfected with Cx43-FP. We
analyzed oligomeric states of Cx43 in living cells using
FRET between Cx43-CFP (donor) and Cx43-YFP (accep-
tor) co-expressed in the same cell. Live cell FRET-FLIM
analyses conﬁrmed that upon oligomerization of Cx43-FP
the donor lifetime was strongly decreased from 2.6–2.4 to
1.9–1.8 ns. The inter-molecular distances between Cx43-
FP molecules in ERES calculated from this data are in the
range from 3–4 to 6.5 nm (with the Ro for the CFP/YFP-
pair known to be 4.9–5.2 nm; Tsien 1998; Burkhardt et al.
1997).
The cytosolic C-terminus of Cx43 contains multiple
sequences for phosphorylation and protein–protein inter-
actions which are extensively under study by several
groups (Giepmans et al. 2001; Butkevich et al. 2004; Park
et al. 2006). We suggest here that close proximity and a
correct ‘‘oligomerized conformation’’ of Cx43 induced by
Sar1H79G may allow consensus phosphorylation at the
Cx43-C-terminus followed by its interactions with 14-3-3
molecules. Indeed, we show that co-expression of Cx43
with Sar1H79G induces accumulation of 14-3-3 proteins in
the ER fraction, whereas co-expression of Cx43 with
Sar1T39N or Cx43 expression alone does not. The crystal
structure of 14-3-3 proteins suggests binding for two
phosphorylated molecules (Fu et al. 2000), supporting our
view on the possible oligomerization of Cx43 in the ER.
Taking into account that 14-3-3 proteins exist in the cytosol
as dimers, and that plausible 14-3-3 interactions with a
Cx43 C-terminal motif have been reconstructed by the
Warn-Cramer group (Park et al. 2006), we speculate that
phosphorylation at and 14-3-3 binding to the C-terminus of
Cx43 induces its lateral segregation in the ER membrane,
oligomerization, and inclusion of these Cx43 assemblies
into ERES. These are the molecular events bringing tagged
Cx43 molecules into close proximity as seen in our FRET-
FLIM data which demonstrate a decreased donor lifetime
(Cx43-CFP) in ERES. Signiﬁcant decrease in the donor
lifetime as observed (from 2.5 to 1.9 ns) occurs only when
the donor/acceptor-pair, Cx43-CFP/Cx43-YFP, is in close
proximity as occurs during oligomerization of Cx43 (see
cartoon in Fig. 7, right panel). All connexins, except Cx26,
are known to be phosphoproteins. In view of the novel
14-3-3/Cx43 interaction presented here, regulated phos-
phorylation of the C-terminal domain of Cx43 by protein
kinases may be important not only for assembly, closure or
opening of channels at the PM, but also for Cx43 exit from
the ER. About ten different kinases have been demon-
strated to be able to phosphorylate Cx43 (for review see
Herve et al. 2007). Thus, a number of different tissue-
speciﬁc and developmentally regulated kinases are expec-
ted to participate in phosphorylation-dependent events.
Uniquely, the C-terminus of Cx43 harbors a 14-3-3
binding motif immediately followed by a potential COPI-
dependent retention motif RxR, RPR (Fig. 2e). Here, we
tested the biological activity of this motif. We show in
living cells that overexpression of the b-subunit of COPI/
coatomer prevents ER exit and Golgi transport of Cx43
(Fig. 4i–k). By two-hybrid analysis it has been shown that
the RPR sequence is recognized by the b- and d-COPI
subunits and that this interaction is important for protein
sorting in yeast (Michelsen et al. 2007). Based on our live
cell analyses and in vitro data obtained by others we sug-
gest that oligomerization and segregation of Cx43 in the
ER, normally induced by 14-3-3 binding, can be sterically
impaired by b-COPI binding. Such a mechanism could be
used for ﬁne regulation of Cx43 transport to the PM via
Fig. 7 Schematic involvement of small GTPases in Cx43 transport.
Left panel Distribution and effects of three small GTPases that act in
the biosynthetic pathway, Sar1, Arf1, and Arf6, on the transport of
Cx43. Differential blocks induced by GDP- and GTP-restricted Sar1
on ER-to-Golgi transport of Cx43: Sar1T39N prevents assembly into
ER exit sites—left, Sar1H79G blocks Cx43 in ER exit sites—right
(monomeric and oligomeric forms of Cx43 are depicted in red). Cx43
exit from the Golgi is blocked by ARF1Q71L. Recycling and removal
of Cx43 at the PM is Arf6-dependent. This step may be important for
regulation of Cx43 at the PM in response to extracellular signals,
migration, or initiation of transformation. Middle panel ER-Golgi-PM
transport of connexins and formation of gap junctions at the cell–cell
interface upon contact. Right panel Possible role of 14-3-3 proteins in
Cx43 oligomerization/segregation into ERES
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123signaling. A 14-3-3 binding motif followed by a COPI
binding motif was not described for connexins before, but
has been shown for some transmembrane receptors and ion
channels (Margeta-Mitrovic 2002; Standley et al. 2000;
Scott et al. 2001). What happens to Cx43 when it is
accumulated in the ER? Locked in the ER, Cx43 may
interact with ER ubiquitin-like family proteins as e.g.
CIP75 (Li et al. 2008) to be subjected to ER-associated
degradation.
Cx43 permeability to small molecules differs in tissues
of different origin such as brain, heart, kidney, and skin.
We infer a mechanistic role of Cx43/14-3-3/b-COPI
interactions observed at the single cell level to explain how
the developmental increase in 14-3-3 expression may favor
surface appearance of Cx43. Cx43 level is elevated in
astrocytes and in early development astrocytes display
the highest degree of dye transfer (our unpublished data).
14-3-3 protein expression levels and the type of isoforms
expressed vary in speciﬁc brain regions and cell types
(Baxter et al. 2002), but generally expression is upregu-
lated during post-natal brain development (Toyooka et al.
2002). Similar mechanisms may be triggered during
tumorigenesis, where reversely a decrease of 14-3-3
expression may cause ER accumulation of Cx43 and
reduced gap junction communication. Our results obtained
at the single cell level reveal how 14-3-3 proteins may
facilitate Cx43 exit from the ER and suggest that 14-3-3
proteins work in concert with other important molecules of
the secretory pathway to bring connexin molecules to the
PM.
We show here that even though oligomerization of Cx43
may proceed correctly, the impairment of dynein-depen-
dent transport step out of the ER can cause the same
phenotype as impaired oligomerization of Cx43. Expres-
sion of the p50/dynamitin subunit of the dynactin complex,
as well as microinjection of anti-dynein antibodies (data
not shown here), prevented arrival of Cx43 oligomers in
the Golgi complex. Strong dependence of the ER-to-Golgi
transport step of Cx43 on intact microtubules was observed
by us and other groups. Here, we demonstrate that when
arrested by p50/dynamitin overexpression, Cx43 resides in
dotted ERES-like structures that co-localize with COPII
components and resemble those seen in Sar1H79G-trans-
fected cells. In cells expressing p50/dynamitin and ﬁxed for
immunoﬂuorescence we were unable to co-localize Cx43
even with the KDEL-receptor, which is cycling between
the ER and the cis-/medial-Golgi. We conclude that in p50-
transfected cells Cx43 containing structures may remain
still associated with the ER membranes, distinct from
KDEL-receptor-positive cis-Golgi structures, and, although
remaining mobile, fail to accumulate/be loaded on existing
intact microtubules (Fig. 4i–l). Since the half-life of Cx43
e.g. in cardiac myocytes is as short as 90 min (Darrow
et al. 1996), fast and regulated delivery of Cx43 to the PM
may be crucial for cell survival in the heart in vivo. In vitro
reconstructions showed that transport of assembled oligo-
meric proteins along microtubules is generally faster and
more progressive than that of their monomeric subunits
(Klopfenstein et al. 2002). It remains to be tested whether
monomeric connexin subunits can move more effectively
along microtubules in living cells.
Normally b-COP and Arf1 co-localize in the Golgi
region, as they tightly function together in COPI vesicle
budding on Golgi membranes. Upon binding of GTP Arf1
translocates from the cytosol onto Golgi membranes and
recruits the coatomer complex (reviewed in Duden 2003).
In this study, we demonstrate that Arf1Q71L blocks Cx43
in the Golgi complex, whereas overexpression of wild-type
Arf1 allows PM appearance of Cx43. Although we could
not resolve 14-3-3 accumulation on the ER membrane
against background signal by ﬂuorescence imaging, a clear
Golgi pattern of 14-3-3 can be seen during Cx43 accu-
mulation in this organelle. How long does the phosphory-
lated C-terminus of Cx43 normally remain associated with
14-3-3? Again, cellular analyses of Cx43 distribution with
line scans revealed an accumulation of 14-3-3 in the Golgi
region (only IF shown here, Fig. 4o–r). Moreover, 14-3-3
proteins can be co-localized with Cx43 at the non-con-
tacting plasma membrane regions, but was never detected
at cell–cell interfaces (see Fig. 4). This may be explained
by the notion that at the cell–cell interface Cx43 has
stronger ‘‘stabilizing’’ interactions (e.g. ZO-1 or drebrin)
that displace 14-3-3 from the C-terminus of Cx43.
Lastly, we describe the novel phenomenon of complete
and rapid Arf6Q67L-dependent removal of Cx43 gap
junctions from the PM. Extracts of cells co-expressing
Cx43 and Arf6Q67L were analyzed by immunoblot. Anti-
Cx43 antibodies revealed strong degradation of Cx43
induced by Arf6Q67L (Fig. 5). However, the gap junction
localization of Cx43-GFP was not affected in cells
expressing the GDP-restricted mutant Arf6T44N. What is
the biological signiﬁcance of the Arf6Q67L effect on Cx43
removal at the tissue level? Arf6 action may be required for
rapid disassembly of Cx43 plaques in developing or
migrating cells as well as during neoplastic transformation
(Krutovskikh 2002). This hypothesis may be supported by
the observation that at the cell periphery Cx43 is colocal-
ized with paxillin, known to be involved in cell migration
processes (Fig. 5e–g). The loss of Cx43-containing gap
junctions in Arf6Q67L expressing cells does not involve
lysosomal accumulation of Cx43. Only proteasomal
inhibitors partially prevented this Arf6Q67L-dependent
disappearance of Cx43 from the cell–cell interface. In
contrast, lysosomes are readily detectable in control cells in
which Cx43-FP alone was expressed. Different GTP- and
GDP-restricted Arf6 mutants were extensively studied by
Histochem Cell Biol (2009) 132:263–280 277
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the production of PIP2 known to enhance clathrin-depen-
dent endocytosis as well as internalization via clathrin-
independent mechanisms (Naslavsky et al. 2004; Jovanovic
et al. 2006). A GDP-restricted Arf6, Arf6T27N, was much
less potent in its ability to decrease the formation of Cx43
gap junctions than Arf6Q67L (data not shown). A
remarkable effect of Arf6Q67L expression was the total
absence of lysosomal staining for Cx43-GFP. Although
massive degradation should occur after Cx43 internaliza-
tion, Cx43-positive lysosomal structures were undetectable
in cells expressing Arf6Q67L.
Data from different groups on the cellular activities of
Arf6 are still controversial. Thus, it was demonstrated that
Arf6Q67L expression inhibits transferrin receptor inter-
nalization (supposed to occur in clathrin-coated vesicles)
without affecting its recycling (Paleotti et al. 2005). Arf6-
GTP was shown to interact speciﬁcally with the PM-spe-
ciﬁc adaptor protein complex AP-2 and promotes its
membrane recruitment. These ﬁndings suggest that Arf6
plays a major role in clathrin-mediated endocytosis by
directly controlling the assembly of the AP-2/clathrin coat.
Several different functions were assigned to ARF6
including endocytosis, membrane recycling, remodeling of
the actin cytoskeleton and others (reviewed by D’Souza-
Schorey and Chavrier 2006). Cx43 is known to be asso-
ciated with different cancers (Mesnil 2002; Oliveira et al.
2005). Controversial data exist for various forms of the
disease, e.g. cervical, prostate, SLC lung cancer, gliomas
and melanomas, as to whether connexin expression (e.g.
Cx43) is downregulated or whether e.g. turnover at the PM
is increased (Herve et al. 2007). In summary, our results
suggest that Arf6 in its active, GTP-bound form may carry
important functions in directing quick disassembly of Cx43
plaques in developing and migrating cells. The fact that
Cx43 in Arf6Q67L-transfected cells co-localized at the cell
periphery with paxillin supports this possibility. It was
shown that expression of Cx43 suppresses the growth of
human glioblastoma cells (Huang et al. 2002). Why do
cells reduce gap junction coupling during neoplastic
transformation? Perhaps this is part of a protective mech-
anism against malignant transformation where cells may
have tendency to limit the spread of apoptotic signaling,
e.g. Ca
2?-mediated waves or other signals that can easily
pass through gap junctions. Thus, investigating the Arf6-
dependence of gap junction communication is important in
the context of understanding the loss of gap junction cou-
pling between cancer cells.
Live cell data presented here provide a framework to
explain how extracellular factors acting via small GTPases
of the secretory pathway may regulate connexin transport to
the cell surface. Interestingly, recent work shows the
importance of intracellular trafﬁcking and stabilization of
Cx43 at the plasma membrane in astrocytes for the survival
of dopaminergic (DA) neurons in a rotenone-induced model
of Parkinson disease (Kawasaki et al. 2009). Gap junction
levels are known to be increased during embryonic devel-
opment. Similar regulation of cell–cell coupling by small
GTPases is likely to be utilized during brain development
when increased formation of speciﬁc neuronal circuits
requires not a bulk ﬂow of connexin molecules to the PM
but speciﬁc regulation and ﬁne tuning of their PM delivery.
Gap junctions provide a platform for cell–cell communi-
cations in neuroepithelium elaborating formation of neu-
ronal circuits in cerebral cortex to serve higher cognitive
functions. Gap junction coupling was shown to regulate
proliferation of neural progenitors during migration and the
differentiation of young neurons in the embryonic cerebral
cortex, acting both in the classical manner by coupling
neural progenitors and through hemichannels that mediate
the spread of calcium waves across cell populations in
migrating neurons (for review see Elias and Kriegstein
2008). Our data thus address regulatory transport mecha-
nisms underpinning cell–cell communication in tissues and
organs. A more detailed understanding is important for the
newly emerging ﬁeld of regenerative medicine that aims to
provide new tools in cell-based therapies.
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